Kapitalo Investimentos Ltda Increases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Kapitalo Investimentos Ltda increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 336.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,100 shares of the healthcare conglomerate’s stock after purchasing an additional 848 shares during the quarter. Kapitalo Investimentos Ltda’s holdings in UnitedHealth Group were worth $579,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Richelieu Gestion SA acquired a new stake in UnitedHealth Group in the 4th quarter worth about $26,000. CGC Financial Services LLC boosted its stake in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares during the last quarter. True Wealth Design LLC acquired a new stake in UnitedHealth Group in the 4th quarter worth about $31,000. LFA Lugano Financial Advisors SA boosted its stake in UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the last quarter. Finally, Transcendent Capital Group LLC acquired a new stake in UnitedHealth Group in the 4th quarter worth about $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock opened at $481.05 on Wednesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The stock’s 50 day moving average is $494.64 and its two-hundred day moving average is $505.02. The company has a market capitalization of $442.75 billion, a PE ratio of 29.40, a P/E/G ratio of 1.42 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the previous year, the business earned $6.26 EPS. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.75%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date is Monday, June 17th. UnitedHealth Group’s payout ratio is 51.34%.

Analysts Set New Price Targets

UNH has been the topic of several research analyst reports. Bank of America reaffirmed a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research note on Thursday, March 7th. Barclays lifted their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Morgan Stanley reduced their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, TD Cowen reduced their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.